A Review of the Relationship between Wnt Signal Transduction Pathway and Endometrial Cancer

Xiaolu Zhu, Jing Chen, Juan Wang, Yincheng Teng, Zhuowei Xue

Article ID: 8161
Vol 38, Issue 7, 2024
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20243807.429
Received: 2 January 2023; Accepted: 2 January 2023; Available online: 20 July 2024; Issue release: 20 July 2024


Download PDF

Abstract

The incidence of endometrial cancer (EC) has been on the rise in recent years. Advanced EC is associated with poor prognosis in patients. Traditional classification methods for EC do not provide satisfactory diagnosis and treatment. With the rapid advancements in molecular biology, studies have associated multi-omics with signaling pathways in the pathogenesis of EC, which is critical for the diagnosis and treatment of patients. Cell signal transduction pathways may lead to the occurrence, development and metastasis of tumors through multiple effectors. The Wnt (Wingless and Int-1) signaling pathway is a highly conserved signaling route that is widely present in multicellular eukaryotes. It is involved in determining cell fate, as well as cell proliferation, differentiation, motility and apoptosis during embryonic development, and its target genes are factors involved in cell development, cell proliferation and cell migration. Abnormal signal transduction may lead to abnormalities in cell growth, differentiation, metabolism and biology, resulting in various diseases. The Wnt pathway may be involved in uterine development and endometrial maintenance, and it is associated with estrogen-induced endometrial proliferation. This paper reviews progress in research on the relationship between Wnt signaling pathway and EC.


Keywords

Wnt signaling pathway;endometrial cancer;signal transduction;estrogen and progesterone;miRNA;lncRNA;m6A


References

Supporting Agencies



Copyright (c) 2024 Xiaolu Zhu, Jing Chen, Juan Wang, Yincheng Teng, Zhuowei Xue




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).